• Is C4 Therapeutics (CCCC) stock outpacing its medical peers this year? MSN Wed, 08 Jul 2026 17:42:32 GMT
• Is C4 Therapeutics (CCCC) Stock Outpacing Its Medical Peers This Year? Yahoo Finance Tue, 07 Jul 2026 13:40:03 GMT
• C4 Therapeutics Q1 2026 Earnings: EPS Beat Estimates by 47.3% Amid Ongoing Clinical Development - Book Value Growth dars.gov.et Mon, 06 Jul 2026 04:37:31 GMT
• C4 Therapeutics, Inc. (CCCC) Is Up 2.65% in One Week: What You Should Know Yahoo Finance Fri, 03 Jul 2026 16:00:03 GMT
• C4 Therapeutics (CCCC) Gains Over the Past Month, Can It Go Higher? Yahoo Finance Fri, 03 Jul 2026 13:11:55 GMT
• Director at C4 Therapeutics (CCCC) takes 3,341 shares as fees Stock Titan Thu, 02 Jul 2026 20:05:30 GMT
• Director of C4 Therapeutics (NASDAQ: CCCC) receives 2,650-share stock award Stock Titan Thu, 02 Jul 2026 20:05:12 GMT
• price to book forward of c4 therapeutics, inc. – nasdaq:cccc TradingView Thu, 02 Jul 2026 05:22:32 GMT
• Price to earnings forward of C4 Therapeutics, Inc. – NASDAQ:CCCC TradingView Thu, 02 Jul 2026 03:59:57 GMT
• price to sales forward of c4 therapeutics, inc. – nasdaq:cccc TradingView Thu, 02 Jul 2026 00:15:27 GMT
• cccc stock climbs as c4 therapeutics posts strong phase 1 myeloma data StocksToTrade Tue, 30 Jun 2026 18:03:00 GMT
• c4 therapeutics, inc.(nasdaqgs: cccc) added to russell 2000 value benchmark marketscreener.com Mon, 29 Jun 2026 15:25:51 GMT
• c4 therapeutics, inc.(nasdaqgs:cccc) added to russell small cap comp value benchmark marketscreener.com Sun, 28 Jun 2026 22:00:00 GMT
• C4 Therapeutics, Inc.(NasdaqGS: CCCC) added to Russell 2500 Value Benchmark marketscreener.com Sun, 28 Jun 2026 07:00:00 GMT
• Form 4 C4 Therapeutics Inc For: 26 June By Investing.com Investing.com Nigeria Sat, 27 Jun 2026 00:41:03 GMT
• c4 therapeutics (nasdaq: cccc) director receives 62,000 stock options at $4.25 Stock Titan Sat, 27 Jun 2026 00:39:23 GMT
• director steven hoerter gets 62,000 c4 therapeutics (cccc) options at $4.25 Stock Titan Sat, 27 Jun 2026 00:31:21 GMT
• C4 Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hoerter Steven L. Moomoo Sat, 27 Jun 2026 00:27:28 GMT
• Director Steven Hoerter gets 62,000 C4 Therapeutics (CCCC) options at $4.25 Stock Titan Fri, 26 Jun 2026 07:00:00 GMT
• C4 Therapeutics (NASDAQ: CCCC) director receives 62,000 stock options at $4.25 Stock Titan Fri, 26 Jun 2026 07:00:00 GMT
• C4 Therapeutics (NASDAQ: CCCC) director receives grant of 62,000 stock options Stock Titan Fri, 26 Jun 2026 07:00:00 GMT
• Director at C4 Therapeutics (CCCC) granted 62,000 stock options at $4.25 Stock Titan Fri, 26 Jun 2026 07:00:00 GMT
• C4 Therapeutics (CCCC) director awarded 62,000 stock options at $4.25 strike Stock Titan Fri, 26 Jun 2026 07:00:00 GMT
• C4 Therapeutics (CCCC) director receives 62,000-share stock option award Stock Titan Fri, 26 Jun 2026 07:00:00 GMT
• C4 Therapeutics (CCCC) director receives grant of 62,000 stock options Stock Titan Fri, 26 Jun 2026 07:00:00 GMT
• C4 Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director GROGAN DONNA ROY Moomoo Fri, 26 Jun 2026 07:00:00 GMT
• Soft Tissue Sarcoma Pipeline 2026: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight | OncoTherapy Science, ... Barchart.com Fri, 26 Jun 2026 07:00:00 GMT
• form 4 c4 therapeutics inc for: 26 june by investing.com Investing.com South Africa Fri, 26 Jun 2026 07:00:00 GMT
• CCCC: All proposals, including director elections and stock plan amendment, passed by majority vote TradingView Wed, 24 Jun 2026 13:22:01 GMT
• c4 therapeutics (nasdaq: cccc) investors approve directors, pay and stock plan change Stock Titan Wed, 24 Jun 2026 07:00:00 GMT
• c4 therapeutics inc (cccc) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 24 Jun 2026 07:00:00 GMT
• c4 therapeutics inc (cccc) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 23 Jun 2026 07:00:00 GMT
• barclays maintains c4 therapeutics(cccc.us) with buy rating, maintains target price $7 Moomoo Mon, 22 Jun 2026 09:31:00 GMT
• c4 therapeutics inc (cccc) valuation: pe, pb & fair value analysis TradingKey Mon, 22 Jun 2026 07:00:00 GMT
• c4 therapeutics inc (cccc) earnings forecast: future eps & revenue growth estimates TradingKey Sun, 21 Jun 2026 07:00:00 GMT
• C4 Therapeutics, Inc. (CCCC) Discusses Evolving Multiple Myeloma Treatments and the Role of IKZF1/3 Degraders Including Cemsidomid... Seeking Alpha Sat, 20 Jun 2026 07:00:00 GMT
• wall street analysts are bullish on top healthcare picks The Globe and Mail Fri, 19 Jun 2026 09:15:00 GMT
• Are Medical Stocks Lagging C4 Therapeutics (CCCC) This Year? Yahoo Finance Thu, 18 Jun 2026 07:00:00 GMT
• Barclays Maintains C4 Therapeutics(CCCC.US) With Buy Rating, Maintains Target Price $7 Moomoo Thu, 18 Jun 2026 07:00:00 GMT
• c4 therapeutics inc (cccc) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• c4 therapeutics inc (cccc) valuation: pe, pb & fair value analysis TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• c4 therapeutics inc (cccc) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• c4 therapeutics inc (cccc) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Wed, 17 Jun 2026 18:48:51 GMT
• c4 therapeutics inc (cccc) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 18:48:48 GMT
• c4 therapeutics inc (cccc) dividends & stock splits: historical payouts and event timeline TradingKey Wed, 17 Jun 2026 18:20:06 GMT
• c4 therapeutics inc (cccc) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 17 Jun 2026 15:04:24 GMT
• c4 therapeutics inc (cccc) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 04:21:16 GMT
• c4 therapeutics inc (cccc) earnings forecast: future eps & revenue growth estimates TradingKey Wed, 17 Jun 2026 03:58:34 GMT
• c4 therapeutics inc (cccc) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 03:58:13 GMT
• c4 therapeutics inc (cccc) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 03:51:58 GMT
• c4 therapeutics inc (cccc) risk assessment: volatility, financial risk & investment risk TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• cccc q1 2026 earnings: narrowing losses highlight cost discipline despite no revenue - earnings expansion phase newsline.com Mon, 15 Jun 2026 21:43:21 GMT
• C4 Therapeutics Ownership Changes Raise Investor Concerns timothysykes.com Mon, 15 Jun 2026 07:00:00 GMT
• c4 therapeutics inc (cccc) earnings forecast: future eps & revenue growth estimates TradingKey Mon, 15 Jun 2026 07:00:00 GMT
• Analysts Are Bullish on These Healthcare Stocks: C4 Therapeutics (CCCC), AbbVie (ABBV) The Globe and Mail Sat, 13 Jun 2026 07:00:00 GMT
• barclays maintains c4 therapeutics(cccc.us) with buy rating, maintains target price $7 Moomoo Fri, 12 Jun 2026 09:31:00 GMT
• C4 Therapeutics Presents Phase 1 Data at European Hematology Association 2026 Congress Highlighting Cemsidomide as a Potential Bes... Investing News Network Fri, 12 Jun 2026 07:00:00 GMT
• c4 therapeutics reports updated cemsidomide data at eha 2026 grafa.com Thu, 11 Jun 2026 16:52:00 GMT
• c4 therapeutics reports 53% response rate for cemsidomide at rp2d marketscreener.com Thu, 11 Jun 2026 12:04:59 GMT
• Heavily pretreated myeloma patients see durable responses on C4 oral therapy Stock Titan Thu, 11 Jun 2026 07:00:00 GMT
• C4 Therapeutics presents cemsidomide data at EHA congress Investing.com Thu, 11 Jun 2026 07:00:00 GMT
• C4 Therapeutics (NASDAQ: CCCC) highlights cemsidomide Phase 1 response rates in RRMM Stock Titan Thu, 11 Jun 2026 07:00:00 GMT
• C4 Therapeutics Presents Phase 1 Data at European Hematology Association (EHA) 2026 Congress Highlighting Cemsidomide as a Potenti... The Manila Times Thu, 11 Jun 2026 07:00:00 GMT
• c4 therapeutics posts phase 1 cemsidomide data and corporate presentation ahead of eha 2026 TradingView Thu, 11 Jun 2026 07:00:00 GMT
• c4 therapeutics (cccc) unveils phase 1 trial insights on cemsido GuruFocus Thu, 11 Jun 2026 07:00:00 GMT
• monte rosa: initiating coverage with a buy on degrader platform potential Seeking Alpha Thu, 11 Jun 2026 07:00:00 GMT
• nurix to work with roche on btk degrader in pact worth up to $2.3b Endpoints News Mon, 08 Jun 2026 07:00:00 GMT
• cccc: cemsidomide shows best-in-class potential in efficacy and safety, targeting a $4b+ market TradingView Thu, 04 Jun 2026 15:08:37 GMT
• c4 therapeutics | 4: statement of changes in beneficial ownership of securities-director anderson kenneth carl Moomoo Thu, 04 Jun 2026 07:00:00 GMT
• director anderson (nasdaq: cccc) exercises 1,070 options at $2.11 Stock Titan Thu, 04 Jun 2026 07:00:00 GMT
• c4 therapeutics, inc. (cccc) reports q1 loss, lags revenue estimates MSN Wed, 03 Jun 2026 05:03:29 GMT
• c4 therapeutics "buy" on cemsidomide advancement and competitor's positive readout (nasdaq:cccc) Seeking Alpha Tue, 02 Jun 2026 14:58:12 GMT
• c4 therapeutics' cemsidomide: a foundational treatment across multiple lines of multiple myeloma? RTTNews Tue, 02 Jun 2026 11:04:00 GMT
• C4 Therapeutics 'Buy' On Cemsidomide Advancement And Competitor's Positive Readout (CCCC) Seeking Alpha Tue, 02 Jun 2026 07:00:00 GMT
• cccc maintained by evercore isi group -- price target raised to $12.00 GuruFocus Mon, 01 Jun 2026 17:28:28 GMT
• C4 Therapeutics (CCCC) Upgraded to Buy: What Does It Mean for the Stock? Yahoo Finance Mon, 01 Jun 2026 07:00:00 GMT
• Has ABCELLERA BIOLG (ABCL) Outpaced Other Medical Stocks This Year? Yahoo Finance Mon, 01 Jun 2026 07:00:00 GMT
• positive data for mezigdomide boosts bristol myers squibb (bmy) and c4 therapeutics (c four) GuruFocus Sat, 30 May 2026 00:11:56 GMT
• Bristol-Myers multiple myeloma data boosts C4 (BMY:NYSE) Seeking Alpha Fri, 29 May 2026 07:00:00 GMT
• Positive Data for Mezigdomide Boosts Bristol Myers Squibb (BMY) and C4 Therapeutics (C FOUR) GuruFocus Fri, 29 May 2026 07:00:00 GMT
• c4 therapeutics (cccc) hits 52-week high following bmy trial suc GuruFocus Fri, 29 May 2026 07:00:00 GMT
• cccc (nasdaq) insider exercise-and-sale: 9,087 options sold from 29,080 grant Stock Titan Fri, 29 May 2026 00:44:03 GMT
• CCCC (NASDAQ) insider exercise-and-sale: 9,087 options sold from 29,080 grant Stock Titan Thu, 28 May 2026 07:00:00 GMT
• c4 therapeutics | 144: notice of proposed sale of securities pursuant to rule 144 Moomoo Thu, 28 May 2026 07:00:00 GMT
• cccc: cemsidomide demonstrates robust late-line efficacy and safety, with global expansion and new combinations planned TradingView Tue, 26 May 2026 19:47:41 GMT
• c4 therapeutics (cccc) 7th annual oncology innovation summit: insights for asco & eha summary Quartr Tue, 26 May 2026 07:00:00 GMT
• Emerging Hope in Multiple Myeloma Market: 7 Late-Stage Therapies Nearing the Finish Line | DelveInsight Yahoo Finance Mon, 25 May 2026 07:00:00 GMT
• c4 therapeutics q1 2026 earnings: strong eps beat highlights cost discipline amid pre-revenue stage - one-time gain impact Newser Sat, 23 May 2026 03:43:45 GMT
• clinical trial participation drives development of innovative treatments, c4 therapeutics, inc. Traders Union Wed, 20 May 2026 14:20:11 GMT
• C4 Therapeutics to Participate in Upcoming Conferences Investing News Network Wed, 20 May 2026 07:00:00 GMT
• c4 therapeutics to speak at td cowen, jefferies, goldman healthcare events Stock Titan Wed, 20 May 2026 07:00:00 GMT
• c4 therapeutics deepens roche alliance to target breakthrough cancer therapies MSN Tue, 19 May 2026 23:30:25 GMT
• c4 therapeutics (nasdaq: cccc) — squadron fund reports 5.55m shares Stock Titan Tue, 19 May 2026 07:00:00 GMT
• c4 therapeutics, inc. to present new cemsidomide phase 1 data at eha hematology 2026 congress Traders Union Mon, 18 May 2026 12:45:52 GMT
• biotech c4 therapeutics gives new hire options on 85,480 shares Stock Titan Mon, 18 May 2026 07:00:00 GMT
• c4 therapeutics announces inducement grant under nasdaq listing rule 5635(c)(4) Moomoo Mon, 18 May 2026 07:00:00 GMT
• c4 therapeutics realigns finance leadership after officer departure The Globe and Mail Sat, 16 May 2026 21:28:00 GMT
• c4 therapeutics realigns finance leadership after officer departure TipRanks Fri, 15 May 2026 21:17:47 GMT
• C4 Therapeutics, Inc. (NASDAQ:CCCC) Just Reported And Analysts Have Been Lifting Their Price Targets Yahoo Finance Fri, 15 May 2026 07:00:00 GMT
• Point72 reports 169,096-share stake in C4 Therapeutics (CCCC) as of Mar 31, 2026 Stock Titan Fri, 15 May 2026 07:00:00 GMT
• c4 therapeutics (cccc) — sirenia/silverstein report 23.5m shares, near 10% stake Stock Titan Fri, 15 May 2026 07:00:00 GMT
• c4 therapeutics, inc. announces executives changes, effective may 15, 2026 marketscreener.com Fri, 15 May 2026 07:00:00 GMT
• are medical stocks lagging c4 therapeutics (cccc) this year? Yahoo Finance Fri, 15 May 2026 07:00:00 GMT
• c4 therapeutics (nasdaq: cccc) names cfo as principal accountant Stock Titan Fri, 15 May 2026 07:00:00 GMT
• c4 therapeutics deepens roche alliance to target breakthrough cancer therapies MSN Thu, 14 May 2026 22:43:11 GMT
• vishay intertechnology, eos energy enterprises, tower semiconductor and other big stocks moving higher on wednesday Sahm Thu, 14 May 2026 11:52:30 GMT
• Degron adds $40M to series A, supporting immunology plans for molecular glue platform BioSpace Thu, 14 May 2026 07:00:00 GMT
• we think c4 therapeutics (nasdaq:cccc) needs to drive business growth carefully Moomoo Thu, 14 May 2026 07:00:00 GMT
• wells fargo maintains c4 therapeutics(cccc.us) with buy rating, maintains target price $10 Moomoo Wed, 13 May 2026 09:31:00 GMT
• C4 Therapeutics (CCCC) Q1 Loss Of US$25.1 Million Reinforces Profitability Concerns simplywall.st Wed, 13 May 2026 07:00:00 GMT
• c4 ditches its egfr degrader | apexonco - clinical trials news and analysis Oncology Pipeline Wed, 13 May 2026 07:00:00 GMT
• vishay intertechnology, eos energy enterprises, tower semiconductor and other big stocks moving higher on Benzinga Wed, 13 May 2026 07:00:00 GMT
• barclays maintains c4 therapeutics(cccc.us) with buy rating, maintains target price $7 Moomoo Wed, 13 May 2026 07:00:00 GMT
• wall street analysts are bullish on top healthcare picks The Globe and Mail Wed, 13 May 2026 07:00:00 GMT
• cccc financials: income statement, balance sheet & cash flow | c4 therapeutics, inc. Stock Titan Tue, 12 May 2026 13:09:07 GMT
• unicycive therapeutics releases q1 2026 financial results AlphaStreet Tue, 12 May 2026 12:54:15 GMT
• c4 therapeutics q1 2026 results: cash reserves total $340.3 million geneonline.com Tue, 12 May 2026 12:25:06 GMT
C4 Therapeutics, Inc(NASDAQ:CCCC) 
C4 Therapeutics, Inc., a biopharmaceutical company, develops novel therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable degrader that is in pr...
Website: http://www.c4therapeutics.com
Founded: 2015
Full Time Employees: 88
CEO: Marc A. Cohen
Sector: Other
Industry: Other